Barclays’s ICU Medical ICUI Stock Holding History

Barclays’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-63,000	Closed	-$14.7M	–	4407
2021 Q3	$14.7M	Buy	+63,000	New	+$13.2M	0.01%	1017
2021 Q2	–	Sell	-17,500	Closed	-$3.6M	–	4954
2021 Q1	$3.6M	Buy	+17,500	New	+$3.7M	﹤0.01%	1792
2020 Q4	–	Sell	-5,500	Closed	-$1M	–	5027
2020 Q3	$1M	Sell	5,500 -2,300	-29%	-$433K	﹤0.01%	2691
2020 Q2	$1.44M	Sell	7,800 -12,200	-61%	-$2.42M	﹤0.01%	2428
2020 Q1	$4.04M	Buy	+20,000	New	+$3.85M	﹤0.01%	1655
2018 Q3	–	Sell	-10,000	Closed	-$2.94M	–	7236
2018 Q2	$2.94M	Buy	+10,000	New	+$2.73M	﹤0.01%	2196

Other funds holding ICUI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Barclays's ICUI Position: Q2 2026 in Review

Barclays reduced its ICU Medical (ICUI) stake by 6.6% in Q2 2026, selling an estimated $39.9K and leaving 4,330 shares worth $635K. The position accounts for ﹤0.01% of the portfolio, ranked #3077.

Barclays first reported a position in ICUI in Q2 2013 and has held it in 51 quarters since. The position peaked at $34.5M in Q3 2021. 289 funds tracked by Wall St. Rank hold ICUI as of Q2 2026.

Barclays held 4,330 shares of ICU Medical worth $635K as of Q2 2026.
Barclays sold 306 ICU Medical shares in Q2 2026, an estimated $39.9K.
ICU Medical made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #3077 holding.
Barclays first reported a position in ICU Medical in Q2 2013 and has held it in 51 quarters since.
Barclays's ICU Medical position peaked at $34.5M in Q3 2021.
289 funds tracked by Wall St. Rank held ICU Medical as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.